- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jubilant Pharmova Limited — Updates, 06-02-2026: Press Release
06-02-2026 | 12:48 pm
06-02-2026 | 12:48 pm
Jubilant Pharmova reported Q3 revenue of 2,123 Cr (+17% YoY) and 9M revenue of 5,990 Cr (+13% YoY). CDMO Sterile Injectables drove growth, with Montreal production resumed post-remediation. Strategic PET Radiopharmacy expansion is underway, though Q3 margins saw temporary impacts.
No comments yet. Be the first to comment!